CGREX | GRSRX | CGREX / GRSRX | |
Total Expense Ratio | 2.19 | 1.34 | 163% |
Annual Report Gross Expense Ratio | 2.19 | 1.34 | 163% |
Fund Existence | 20 years | 11 years | - |
Gain YTD | 5.189 | 8.475 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133M | 2.01B | 7% |
Annual Yield % from dividends | 1.29 | 2.29 | 57% |
Returns for 1 year | 5.70 | 8.53 | 67% |
Returns for 3 years | -9.21 | 8.74 | -105% |
Returns for 5 years | -0.81 | 32.80 | -2% |
Returns for 10 years | -13.94 | 41.43 | -34% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WMGCX | 18.29 | 0.18 | +0.99% |
Macquarie Mid Cap Growth C | |||
GMVIX | 16.74 | 0.15 | +0.90% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
SBQUX | 13.39 | 0.12 | +0.90% |
AmericaFirst Alpha Trends Factor Class U | |||
PHLCX | 12.13 | 0.06 | +0.50% |
PGIM Jennison Health Sciences C | |||
AQGNX | 12.24 | 0.02 | +0.16% |
AQR Global Equity N |